Business Description
Lipocine is a US-based drug development company focused on creating oral treatments for hormonal conditions, liver disease, and disorders of the brain and nervous system. Its flagship product, TLANDO, is an approved oral testosterone therapy, while several other candidates are advancing through clinical trials targeting conditions such as postpartum depression, obesity, and epilepsy. The company's work centers on improving how the body absorbs and uses existing therapeutic compounds by applying its own proprietary delivery technology. Founded in 1997 and based in Salt Lake City, Utah, Lipocine also works with Verity Pharmaceuticals to bring select testosterone therapies to market.
